Stock listing
Edgewise Therapeutics, Inc.
Selected listing: EWTX · NASDAQ · USD · US
Edgewise Therapeutics, Inc. (NASDAQ:EWTX), Health Technology. Latest release Oct 1, 2026: Edgewise Therapeutics Reports Inducement Grants as permitted…
- Ticker
- NASDAQ:EWTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. (Ticker: EWTX) is a public company based in the United States, focusing on innovative therapies for muscle disorders. The company is actively engaged in research and development to address unmet medical needs in its field.
Latest news from Edgewise Therapeutics, Inc.
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
September 30, 2026
Edgewise Therapeutics Unveils the Differentiated Mechanism of Action (MoA) of its Cardiac Sarcomere Modulator EDG-7500
September 22, 2026
Edgewise Therapeutics : Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026
August 24, 2026
Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026
August 24, 2026
Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
July 13, 2026
Research Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. company profile
View the public company page for Edgewise Therapeutics, Inc. on 6ix.
Edgewise Therapeutics, Inc. news
Read company news and market updates connected to Edgewise Therapeutics, Inc..
Edgewise Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Edgewise Therapeutics, Inc..